| Medical and Health Sciences | 2021-2025 | 731 | US 251 | 99.84 |
| Nephrology | Lifetime | 42 | US 26 | 99.68 |
| Pulmonary and Respiratory Medicine | Lifetime | 524 | US 278 | 99.27 |
| Medical Genetics | Lifetime | 874 | US 433 | 88.97 |
| Nephrology | 2021-2025 | 15 | US 5 | 99.68 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 191 | US 63 | 98.57 |
| Immunology | 2021-2025 | 439 | US 161 | 87.92 |
| Pathology and Forensic Medicine | 2021-2025 | 336 | US 111 | 88.35 |
| Rheumatology | 2021-2025 | 326 | US 105 | 88.23 |
| Medical Genetics | 2021-2025 | 264 | US 119 | 85.11 |
| Renal Diseases and Glomerulopathies | Lifetime | 11 | US 8 | 99.79 |
| Vasculitis and related conditions | Lifetime | 15 | US 9 | 99.75 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 23 | US 15 | 99.44 |
| Complement system in diseases | Lifetime | 42 | US 19 | 99.17 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 77 | US 33 | 98.96 |
| Autoimmune Bullous Skin Diseases | Lifetime | 92 | US 33 | 98.96 |
| Chronic Kidney Disease and Diabetes | Lifetime | 148 | US 69 | 99.06 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 173 | US 70 | 97.36 |
| Platelet Disorders and Treatments | Lifetime | 635 | US 250 | 96.91 |
| Nephrotoxicity and Medicinal Plants | Lifetime | 61 | US 21 | 94.26 |
| Systemic Sclerosis and Related Diseases | Lifetime | 662 | US 206 | 95.70 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 220 | US 55 | 93.85 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 588 | US 228 | 90.37 |
| Biomedical Research and Pathophysiology | Lifetime | 733 | US 297 | 87.07 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 903 | US 211 | 80.39 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 6 | US 2 | 99.78 |
| Vasculitis and related conditions | 2021-2025 | 6 | US 3 | 99.62 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 50 | US 19 | 98.66 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 64 | US 18 | 97.59 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 50 | US 17 | 96.98 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 79 | US 29 | 96.89 |
| Complement system in diseases | 2021-2025 | 61 | US 18 | 96.05 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 323 | US 68 | 91.58 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 122 | US 27 | 87.71 |
| Biomedical Research and Pathophysiology | 2021-2025 | 75 | US 15 | 84.53 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 439 | US 137 | 82.10 |
| Platelet Disorders and Treatments | 2021-2025 | 914 | US 206 | 79.46 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 587 | US 134 | 64.65 |
